The cAMP signaling pathway as a therapeutic target in lymphoid malignancies.
about
Direct detection of diverse metabolic changes in virally transformed and tax-expressing cells by mass spectrometryDevelopmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4Regulation of T-cell activation by phosphodiesterase 4B2 requires its dynamic redistribution during immunological synapse formationDelineation of RAID1, the RACK1 interaction domain located within the unique N-terminal region of the cAMP-specific phosphodiesterase, PDE4D5.Systemic immunoresponses in mice after repeated exposure of lungs to spores of Streptomyces californicus.Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein BimData recovery and integration from public databases uncovers transformation-specific transcriptional downregulation of cAMP-PKA pathway-encoding genes.Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesisCREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal.The cAMP-specific phosphodiesterase TbPDE2C is an essential enzyme in bloodstream form Trypanosoma bruceiInsights into gene expression changes impacting B-cell transformation: cross-species microarray analysis of bovine leukemia virus tax-responsive genes in ovine B cellsInvolvement of GSK-3beta and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells.Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messengerProtein kinases in the regulation of apoptosis in B-cell chronic lymphocytic leukemia.Developmental estrogen exposures predispose to prostate carcinogenesis with aging.Gap junctions and the propagation of cell survival and cell death signals.Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatmentG protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer.Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells.Epstein-Barr Virus (EBV)-BamHI-A Rightward Transcript (BART)-6 and Cellular MicroRNA-142 Synergistically Compromise Immune Defense of Host Cells in EBV-Positive Burkitt Lymphoma.An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways.Pharmacologic interception in T-cell leukemia 1A associated pathways as a treatment rationale for chronic lymphocytic leukemia.Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.Changes of plasma membrane properties in a human pre-T cell line undergoing apoptosis.DeltaRaf-1:ER* bypasses the cyclic AMP block of extracellular signal-regulated kinase 1 and 2 activation but not CDK2 activation or cell cycle reentry.Protein kinase A gating of a pseudopodial-located RhoA/ROCK/p38/NHE1 signal module regulates invasion in breast cancer cell lines.Differential phosphodiesterase expression and cytosolic Ca2+ in human CNS tumour cells and in non-malignant and malignant cells of rat origin.The pro-apoptotic protein Bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells.Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation.Cytotoxic T lymphocyte antigen-2 alpha induces apoptosis of murine T-lymphoma cells and cardiac fibroblasts and is regulated by cAMP/PKA.Involvement of cAMP in nerve growth factor-triggered p35/Cdk5 activation and differentiation in PC12 cells.Head and neck cancers, the neglected malignancies: present and future treatment strategies.A small molecule screen to identify regulators of let-7 targets.
P2860
Q21562168-0EC12B00-634C-4AE2-ABF9-C059B25928C9Q24648201-F75791AC-C93D-45E7-9C27-86F5AC71919BQ24650027-1E0BED8B-8F12-46E5-9145-704DBA99D5C4Q24801846-A4FC257E-0F18-49D2-B700-E896D4C4A60CQ28388543-002F9716-BEB2-4515-8FED-E75BC694FB70Q28591851-E5DDFC1F-B777-45CA-B35C-1FCCA8B8B08BQ33510461-1606751F-5C9D-4D4F-91A1-6AE28560878DQ33642456-637AC3AA-E9DB-4028-95A2-0568F1E13415Q33968736-101AD47D-8391-4814-BD90-0EEA38B7DBF8Q34047854-772D180E-E26C-4EA9-8208-992E643C671AQ34353406-88590BF3-676E-4DF4-B1CA-58ADAC49BEEDQ34574589-2AED5979-BDF9-4934-8DE8-5CCF452A0350Q35074567-1C0DDDBC-A2E0-4D42-BE3C-E89C8E15299DQ35635542-3258C01E-2A72-4A7F-A6B0-F96F2A8B1772Q35903630-F81C3A0D-03AF-43B0-BE0E-9B15EE9A7978Q36134877-B6A442D6-86EC-4F5C-BD08-186933846DC9Q36334968-886C15C1-C52F-4B6F-9F03-DB9549CB0A31Q36503940-0F8E17B2-FE04-4D2E-9783-3437B51586DCQ37293340-88BF2E0B-0BB6-4D2B-9595-DCD691A25505Q37947681-C3E8E99A-D817-4E33-A9E4-621A58C6D35FQ38310967-38C63471-7C35-495F-AD57-DEC0CCA2656DQ38735060-F10B8CCD-8DD4-49E9-98DD-DF71DADE8E3FQ39461997-704F2BCA-04B0-4AB4-806E-7FEE549CD786Q39850208-56F9C300-EDD8-4CE2-A00B-95C8F0963397Q40251414-BE182150-777A-46DF-BCC3-FD985D57A4C9Q40375655-A5D49180-0CA8-4B21-B072-BB0ABA83F92AQ40408138-DB899723-29A9-4D73-9F18-4BD4FAA966A0Q40432766-DF3D3793-96B7-4160-959E-E99E97DB69C4Q40437564-A25B6959-1919-4BD4-8A8B-52F12408E466Q40583071-879B8F5B-BC49-4729-93E9-719A14D66CD5Q40615148-8981B099-C6A7-4615-99F4-CB7783C778F1Q42851123-AEE7828A-EEE3-4C73-AE20-EA56BAA6E2F1Q43654475-FB2A24C4-3152-45F0-B321-9F06A25C7848Q44655644-E3755606-5510-4BE9-9F5C-64D64B31BD92Q46377712-CED307C2-ED49-418D-AFE4-676C7ECF604F
P2860
The cAMP signaling pathway as a therapeutic target in lymphoid malignancies.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The cAMP signaling pathway as a therapeutic target in lymphoid malignancies.
@ast
The cAMP signaling pathway as a therapeutic target in lymphoid malignancies.
@en
type
label
The cAMP signaling pathway as a therapeutic target in lymphoid malignancies.
@ast
The cAMP signaling pathway as a therapeutic target in lymphoid malignancies.
@en
prefLabel
The cAMP signaling pathway as a therapeutic target in lymphoid malignancies.
@ast
The cAMP signaling pathway as a therapeutic target in lymphoid malignancies.
@en
P1433
P1476
The cAMP signaling pathway as a therapeutic target in lymphoid malignancies
@en
P356
10.3109/10428190009057627
P50
P577
2000-03-01T00:00:00Z